Moreover, the results showed that percentageof the CD16+ NK cells from responsive DLBCL patients wasmore than refractory/relapsed DLBCL patients in the absenceof exosomes or presence of IL-2/IL-15 (P=0.0001 and P=0.002,respectively). The gene discussed is IL2; the disease is diffuse large B-cell lymphoma.